Exercise as a therapeutic option for acute kidney injury: mechanisms and considerations for the design of future clinical studies.
Anam AsadJames O BurtonDaniel S MarchPublished in: BMC nephrology (2020)
Acute kidney injury (AKI) is a known risk factor for chronic kidney disease (CKD) and end stage kidney disease (ESKD). The progression from AKI to CKD, despite being well recognised, is not completely understood, although sustained inflammation and fibrosis are implicated. A therapeutic intervention targeting the post AKI stage could reduce the progression to CKD, which has high levels of associated morbidity and mortality. Exercise has known anti-inflammatory effects with animal AKI models demonstrating its use as a therapeutic agent in abrogating renal injury. This suggests the use of an exercise rehabilitation programme in AKI patients following discharge could attenuate renal damage and improve long term patient outcomes. In this review article we outline considerations for future clinical studies of exercise in the AKI population.
Keyphrases
- acute kidney injury
- chronic kidney disease
- end stage renal disease
- cardiac surgery
- high intensity
- physical activity
- resistance training
- oxidative stress
- randomized controlled trial
- peritoneal dialysis
- current status
- newly diagnosed
- ejection fraction
- cancer therapy
- body composition
- drug delivery
- study protocol
- patient reported outcomes
- liver fibrosis